Top News: #InfusionTherapy


Here are the top read news for #infusiontherapy:


man with nausea holding stomachDrug that prevents chemotherapy-induced nausea and vomiting wins FDA approval:

The US Food and Drug Administration (FDA) say that Varubi, a “human substance P/neurokinin-1 (NK-1) receptor antagonist,” was evaluated in three phase 3 clinical trials involving 2,800 adults. Read more


FDA Provides List of Compatible Devices for Treanda Injection:

Last March, the FDA warned health care professionals not to use chemotherapy drug bendamustine (Treanda, Teva Pharmaceutical Industries) with closed system transfer devices (CSTDs), adapters and syringes containing polycarbonate or acrylonitrile-butadiene-styrene (ABS). Read more


Patients Show Their Preference for SubQ IVIG:

Given a choice of immune globulin G (IgG) administration, most patients prefer to receive subcutaneous treatment less frequently, according to a study by Baxter Healthcare. Read more


Study compares hospitalized infection risk for biologics in RAStudy compares hospitalized infection risk for biologics in RA:

For patients with rheumatoid arthritis (RA) with prior biologic exposure, the risk of hospitalized infection is increased with etanercept, infliximab, and rituximab versus abatacept, according to a study published online Aug. 28 in Arthritis & RheumatologyRead more